(Q22252252)

PubMed

PubMed publication ID

7 February 2023

Graham Pawelec

1

Graham

Pawelec

1 reference

PubMed

PubMed publication ID

7 February 2023

3

Anis

Larbi

Anis Larbi

1 reference

PubMed

PubMed publication ID

20656212

Critical Reviews in Oncology Hematology

7 February 2023

language of work or name

English

0 references

publication date

August 2010

0 references

published in

0 references

volume

75

0 references

issue

2

0 references

page(s)

165-172

0 references

cites work

High frequencies of functionally impaired cytokeratin 18-specific CD8+ T cells in healthy HLA-A2+ donors.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1alpha

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Follicular lymphoma B cells induce the conversion of conventional CD4+ T cells to T-regulatory cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Frequency and clinical significance of human beta-herpesviruses in cervical samples from Italian women

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Functional assay for human CD4+CD25+ Treg cells reveals an age-dependent loss of suppressive activity

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Cytomegalovirus and human immunosenescence

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Role of cytomegalovirus in the T cell changes seen in elderly individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Immunosenescence and vaccine failure in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Contribution of the PD-L1/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Mechanisms of murine dendritic cell antitumor dysfunction in aging

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Immunosenescence and cancer vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Cancer, aging and immunotherapy: lessons learned from animal models

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

The effect of aging on OX40 agonist-mediated cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Vaccination strategies in patients with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Use of CD40L immunoconjugates to overcome the defective immune response to vaccines for infections and cancer in the aged

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Impact of aging on cancer immunity and immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Relationship between viral factors, axillary lymph node status and survival in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

CD4+CD25+ T regulatory cells inhibit cytotoxic activity of CTL and NK cells in humans-impact of immunosenescence.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Biomarkers of human immunosenescence: impact of Cytomegalovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Aging and the dendritic cell system: implications for cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

The inflammatory micro-environment in tumor progression: the role of tumor-associated macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Tumor-induced modulation of dendritic cell function

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Are regulatory T-cells linked with aging?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Tumor-specific regulatory T cells in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Decline of T cell-related immune functions in cancer patients and an attempt to restore them through infusion of activated autologous T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Aging and human CD4(+) regulatory T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Do autochthonous tumors interfere with effector T cell responses?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Immunity to methylcholanthrene-induced tumours in inbred rats following atrophy and regression of the implanted tumours

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Adaptive immunity maintains occult cancer in an equilibrium state

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Cancer immunoediting: from immunosurveillance to tumor escape

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Myeloid-derived suppressor cells as regulators of the immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Cytomegalovirus, Epstein-Barr virus and risk of breast cancer before age 40 years: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

T-regulatory cell modulation: the future of cancer immunotherapy?

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Tumor-derived TGF-beta mediates conversion of CD4+Foxp3+ regulatory T cells in a murine model of pancreas cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

The number of human peripheral blood CD4+ CD25high regulatory T cells increases with age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Increase in tumour-infiltrating lymphocytes with regulatory T cell immunophenotypes and reduced zeta-chain expression in nasopharyngeal carcinoma patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Gene expression changes in long-term culture of T-cell clones: genomic effects of chronic antigenic stress in aging and immunosenescence

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Human T‐cell clones in long‐term culture as a model of immunosenescence

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Polarized immune responses differentially regulate cancer development

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

The flip side of immune surveillance: immune dependency

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

The significance of OX40 and OX40L to T-cell biology and immune disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Conditions that diminish myeloid-derived suppressor cell activities stimulate cross-protective immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Association of human beta-herpesviruses with the development of cervical cancer: bystanders or cofactors

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Cytomegalovirus seropositivity is significantly associated with mycosis fungoides and Sézary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Cytomegalovirus seroprevalence is not higher in patients with mycosis fungoides/Sezary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

The flow cytometric analysis of telomere length in antigen-specific CD8+ T cells during acute Epstein-Barr virus infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

SELDI-TOF-MS ProteinChip array profiling of T-cell clones propagated in long-term culture identifies human profilin-1 as a potential bio-marker of immunosenescence

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Immunity, ageing and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

DCVax-Brain and DC vaccines in the treatment of GBM

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Myeloid-derived suppressor cells down-regulate L-selectin expression on CD4+ and CD8+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Clonal Expansions in Acute EBV Infection Are Detectable in the CD8 and not the CD4 Subset and Persist with a Variable CD45 Phenotype

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021

Functional regulatory T cells accumulate in aged hosts and promote chronic infectious disease reactivation

1 reference

https://api.crossref.org/works/10.1016%2FJ.CRITREVONC.2010.06.012

7 January 2021